Glycologic Limited develops carbohydrate based products for the food and drink, clinical nutrition and pharmaceutical sectors. These products include active nutritional ingredients (ANIs), active pharmaceutical ingredients (APIs), delivery systems and diagnostics. The Company collaborates with a broad range of companies to market these technologies and to develop products on a one to one basis.
Based in the UK (Glasgow) the Company has an extensive range of national and international partners with customers located throughout the world. Nutrition, over the counter (OTC) and prescription only medicine (POM or Rx) ingredients used in many healthcare products have been developed by the Company and act to optimise health and protect against disease.
Glycologic Limited develops carbohydrate based/focussed APIs, ANIs, matrices and diagnostics targeted at specific biological needs. These are built from concepts created within (and outside) the Company based on external demand. Once developed, the technologies are tested extensively in our laboratories, then in trials and are scaled up eventually to create commercial products. Sometimes the technologies are defined and protected in the patenting process and associated with post patent publications. At other times the know-how and intellectual property are kept secret unless disclosed under specific commercial agreements with collaborators. The Company develops income by licensing its capabilities and technologies to relevant partners.
Biochemistry & Molecular Biology Services
Glycologic has not received any reviews.
Glycologic has not received any endorsements.